Publications by authors named "Alain Matthey"

Claim this Profile
U
Uncovering a Genetic Polymorphism Located in Huntingtin Associated Protein 1 in Modulation of Central Pain Sensitization Signaling Pathways.
Yvonne Gloor, Alain Matthey, Komla Sobo, Médéric Mouterde, Eva Kosek

Front Neurosci· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity.
Gaëlle Magliocco, Jules Desmeules, Alain Matthey, Luis M Quirós-Guerrero, Nasim Bararpour

Br J Pharmacol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteers.
Alain Matthey, Youssef Daali, François Curtin, Antoine Poncet, Jules Desmeules

Eur J Pain· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of CYP2D6 Functional Allelic Variations on Phenoconversion and Drug-Drug Interactions.
Flavia Storelli, Alain Matthey, Sébastien Lenglet, Aurélien Thomas, Jules Desmeules

Clin Pharmacol Ther· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesia.
William T Ralvenius, Mario A Acuña, Dietmar Benke, Alain Matthey, Youssef Daali

Neuropharmacology· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.
Selidji T Agnandji, Angela Huttner, Madeleine E Zinser, Patricia Njuguna, Christine Dahlke, Alain Matthey

N Engl J Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial.
Angela Huttner, Julie-Anne Dayer, Sabine Yerly, Christophe Combescure, Floriane Auderset, Alain Matthey

Lancet Infect Dis· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up.
Tobias Derfuss, François Curtin, Claudia Guebelin, Claire Bridel, Maria Rasenack, Alain Matthey

J Neuroimmunol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.
Tobias Derfuss, François Curtin, Claudia Guebelin, Claire Bridel, Maria Rasenack, Alain Matthey

Mult Scler· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GABAergic modulation in central sensitization in humans: a randomized placebo-controlled pharmacokinetic-pharmacodynamic study comparing clobazam with clonazepam in healthy volunteers.
Marie Besson, Alain Matthey, Youssef Daali, Antoine Poncet, Pascal Vuillemier

Pain· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P-glycoprotein: a clue to vitamin K antagonist stabilization.
Liliane Gschwind, Victoria Rollason, Françoise Boehlen, Michela Rebsamen, Christophe Combescure, Alain Matthey

Pharmacogenomics· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trial.
Alain Matthey, Christine Cedraschi, Valerie Piguet, Marie Besson, Jocelyne Chabert

Pain Physician· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatment.
Liliane Gschwind, Victoria Rollason, Françoise Boehlen, Michela Rebsamen, Christophe Combescure, Alain Matthey

Pharmacogenomics· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis